MRK Financial Facts

Sales: 23.64B
Restructuring costs: 545.6M
See Full Income Statement

Dividends payable: 0
Total Equity: 18.28B
See Full Balance Sheet

Merck & Co. Inc. (MRK) Earnings

  |   Expand Research on MRK
Next EPS Date 8/2/21 *Est. EPS Growth Rate -6.7% *Last Qtr.
Average EPS % Beat Rate +8.7% Revenue Growth Rate +0.4% *Last Qtr.
Average % Move 1-Wk after EPS -0.8% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
2/3/11 Q410 $0.88$0.83 +$0.05$12.1B$11.53B = Details
10/29/10 Q310 $0.85$0.82 +$0.03N/AN/A N/A Details
4/28/15 Q115 $0.85$0.74 +$0.11$9.4B$9.04B Details
10/25/18 Q318 $1.19$1.12 +$0.07$10.8B$10.88B = Details
10/27/15 Q315 $0.96$0.92 +$0.04$10.1B$10.11B Details
2/5/14 Q413 $0.88$0.88 $0.00$11.3B$11.39B = Details
2/2/17 Q416 $0.89$0.89 $0.00$10.1B$10.22B = Details
4/29/14 Q114 $0.88$0.79 +$0.09$10.3B$10.44B = Details